Loading
Latest filing published 28 Sept 2026 for DarioHealth Corp.. Read the official filing
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Filings by Dennis Matheis span 2 companies, the busiest being DarioHealth Corp. and Lucid Diagnostics Inc. We count 10 filings; the first trade dates from 6 March 2024 and the latest from 24 September 2026.
On the market, this insider has only ever bought: 4 purchases, €604k in total. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 5 share grants. In 2026 alone, the filings show 1 purchase and no sales.
A typical purchase (the median) is worth €151k. None of the 3 purchases we analysed coincided with buying by another insider of the same company within 30 days.
The latest filing, published on 28 September 2026, reports a share grant in DarioHealth Corp. The last insider purchase was made public on 28 July 2026, 82 days ago. Typically, a trade is published a median of 4 days after it takes place. For comparison, the SEC allows two business days to file a Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 of 10 declarations